Atopic Dermatitis-Like Skin Disease in Pediatric Heart Transplant Patients

Oregano Ointment vs. Standard Treatment for Pediatric Atopic Dermatitis

NCT02289989 ·Status: TERMINATED ·Phase: NA

Treatment of Nighttime Pruritus in Atopic Dermatitis

NCT03688464 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1

Moisturizer to Prevent Atopic Dermatitis

NCT03808532 ·Status: WITHDRAWN ·Phase: PHASE2

Asthma, Missed Immunizations, and Vitamin D Deficiency in Atopic Dermatitis

NCT01234909 ·Status: TERMINATED

The Purpose of This Study is to Evaluate the Effects of Ruxolitinib Cream on Adults With Atopic Dermatitis Experiencing Sleep Disturbance.

NCT05696392 ·Status: TERMINATED ·Phase: PHASE4

Improvement In Scratch Behavior And Sleep In Patients With Atopic Dermatitis

NCT05200403 ·Status: TERMINATED ·Phase: PHASE4

A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children With Atopic Dermatitis (TRuE-AD3)

NCT04921969 ·Status: COMPLETED ·Phase: PHASE3

Evaluating Skin Barrier Dysfunction in Infants at High Risk of Atopy

NCT03089476 ·Status: WITHDRAWN ·Phase: NA

Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis

NCT05042258 ·Status: RECRUITING ·Phase: PHASE4

Systemic Therapies for Pediatric Atopic Dermatitis

NCT01447381 ·Status: UNKNOWN

Efficacy and Tolerability of HAT1 in Patients With Moderate to Severe Atopic Dermatitis

NCT03059693 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Comprehending Atopic Risk Elements

NCT04325451 ·Status: UNKNOWN

Study of Immunoadsorption to Treat Severe Atopical Dermatitis Associated With Excessively High Serum IgE Levels

NCT00616096 ·Status: COMPLETED ·Phase: NA

Topical YR001 Ointment in Adult With Mild to Moderate Atopic Dermatitis

NCT06309355 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis With Inadequate Response to or for Whom Cyclosporine A is Not Medically Advisable

NCT05056779 ·Status: WITHDRAWN ·Phase: PHASE3

A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Repeated-dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis

NCT06055374 ·Status: WITHDRAWN ·Phase: PHASE1

A Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis

NCT03257644 ·Status: COMPLETED ·Phase: PHASE1

Study of Ruxolitinib Cream in Children With Atopic Dermatitis

NCT05034822 ·Status: COMPLETED ·Phase: PHASE1

Topical NF-kappaB Decoy in the Treatment of Atopic Dermatitis

NCT00125333 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Atopic Dermatitis (AD) and Food Allergy

NCT03168113 ·Status: COMPLETED

Description of the Population With Moderate to Severe Atopic Dermatitis, Treated by Systemic Treatments and Needs Regarding Emollients

NCT06983561 ·Status: COMPLETED

Targeted Microbiome Transplant in Atopic Dermatitis

NCT03151148 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics (PK)/Pharmacodynamics (PD) of MOR106 in Subjects With Moderate to Severe Atopic Dermatitis

NCT03568071 ·Status: TERMINATED ·Phase: PHASE2

A Study to Evaluate the Safety and Tolerability of MOR106 Administered Concomitantly With Topical Corticosteroids, in Adult Participants With Moderate to Severe Atopic Dermatitis

NCT03864627 ·Status: TERMINATED ·Phase: PHASE2

Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis

NCT03389893 ·Status: TERMINATED ·Phase: PHASE4